<div id="readability-page-1"><p>Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) CFO Jeffry Keyes sold 8,627 shares of Quantum-Si stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $11,042.56. Following the completion of the transaction, the chief financial officer owned 1,163,197 shares of the company's stock, valued at approximately $1,488,892.16. This trade represents a 0.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.</p><h2>Quantum-Si Price Performance</h2><ul><li>Penny Stock Quantum-Si Incorporated Readies For Lift-Off</li></ul><p>NASDAQ:QSI remained flat at $1.27 during mid-day trading on Monday. 5,071,186 shares of the company traded hands, compared to its average volume of 3,958,795. Quantum-Si Incorporated has a 52-week low of $0.95 and a 52-week high of $5.77. The firm's fifty day simple moving average is $1.66 and its 200-day simple moving average is $1.58. The company has a market capitalization of $273.67 million, a P/E ratio of -1.90 and a beta of 2.97. </p><p>Quantum-Si (NASDAQ:QSI - Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The company reported ($0.17) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.17). The business had revenue of $0.55 million during the quarter, compared to analysts' expectations of $0.60 million. Quantum-Si had a negative net margin of 3,677.97% and a negative return on equity of 47.90%.  As a group, equities analysts anticipate that  Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year. </p><h2>Analyst Ratings Changes</h2><p>QSI has been the topic of several research reports. Weiss Ratings  reaffirmed a &#34;sell (e+)&#34; rating on shares of Quantum-Si in a report on Monday, December 8th. Canaccord Genuity Group decreased their price target on shares of Quantum-Si from $2.00 to $1.50 and set a &#34;hold&#34; rating for the company in a research note on Monday. Two analysts have rated the stock with a Buy rating, one  has issued  a Hold rating and one  has given a Sell rating to the company. According to data from MarketBeat, Quantum-Si presently has an average rating of &#34;Hold&#34; and a consensus target price of $3.60.</p><p><b>Read Our Latest Stock Analysis on QSI</b></p><h2>Institutional Inflows and Outflows</h2><p>Institutional investors and hedge funds have recently made changes to their positions in the company. Prudential Financial Inc. purchased a new stake in  Quantum-Si in the 2nd quarter valued at approximately $25,000.  JTC Employer Solutions Trustee Ltd acquired a new position in  Quantum-Si during the second quarter worth $26,000.  Cerity Partners LLC purchased a new position in  Quantum-Si in the second quarter worth $29,000.  Wolverine Asset Management LLC lifted its holdings in  Quantum-Si by 140.0% in the second quarter. Wolverine Asset Management LLC now owns 16,501 shares of the company's stock valued at $32,000 after acquiring an additional 9,626 shares during the period.  Finally, Capital Investment Advisory Services LLC boosted its position in shares of  Quantum-Si by 100.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company's stock worth $28,000 after purchasing an additional 10,000 shares in the last quarter. 39.90% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Quantum-Si Company Profile</h2> (Get Free Report)<p>Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods. </p><p>Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Quantum-Si</li><li>Nvidia CEO Issues Bold Tesla Call</li><li>How Long Will $1M Last in Retirement?</li><li>[No Brainer Gold Play]: “Show me a better investment.”</li><li>Protect Your Bank Account with THESE 4 Simple Steps</li><li>End of America update</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UVNJ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UVNJ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Quantum-Si Right Now?</h2><p>Before you consider Quantum-Si, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.</p><p>While Quantum-Si currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Quantum-Si CFO Jeffry Keyes sold 8,627 shares for $11,042.56, reducing his ownership by 0.74%. The stock price remained flat at $1.27. Quantum-Si has a market cap of $273.67 million and a negative P/E ratio. Analysts have mixed ratings, with a consensus target price of $3.60. Institutional investors have adjusted their positions, with 39.90% ownership. Quantum-Si develops proteomics solutions using semiconductor sequencing technology.</p>

Insider Selling: Quantum-Si (NASDAQ:QSI) CFO Sells $11,042.56 in Stock